Sugi Predict

Sugi Predict / Compounds / SCHEMBL23611469

SCHEMBL23611469

SCHEMBL23611469

CCOC(COCCOCCOCCOCCOS(=O)(=O)c1ccc(C)cc1)OCC

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 6/20 0.40
▸ CA12 O43570 2/20 0.39
▸ CA9 Q16790 2/20 0.39
▸ CA1 P00915 1/20 0.39
▸ MMP2 P08253 1/20 0.35
▸ MMP9 P14780 1/20 0.35
▸ MMP8 P22894 1/20 0.35
▸ MMP13 P45452 1/20 0.35
▸ STAT3 P40763 1/20 0.35
▸ PLA2G2C Q5R387 1/20 0.35
▸ KDM4E B2RXH2 1/20 0.34
▸ HPGD P15428 1/20 0.34
▸ KMT2A Q03164 2/20 0.33
▸ GAA P10253 2/20 0.33
▸ DHODH Q02127 1/20 0.33
▸ VDR P11473 1/20 0.33
▸ CA2 P00918 1/20 0.33
▸ CYP3A4 P08684 1/20 0.33
▸ CYP2C9 P11712 1/20 0.33
▸ CYP2C19 P33261 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21458960 0.99 CA12 (0.40) ALDH1A1CA12CA9CA1MMP2
SCHEMBL8796338 0.92 CA12 (0.38) ALDH1A1CA12CA9CA1MMP2
SCHEMBL9019152 0.89 CA12 (0.41) ALDH1A1CA12CA9CA1STAT3
SCHEMBL9019157 0.89 CA12 (0.41) ALDH1A1CA12CA9CA1STAT3
SCHEMBL30244604 0.86 ALDH1A1 (0.42) ALDH1A1CA12CA9CA1MMP2
SCHEMBL30380176 0.86 ALDH1A1 (0.42) ALDH1A1CA12CA9CA1MMP2
SCHEMBL30244603 0.86 ALDH1A1 (0.42) ALDH1A1CA12CA9CA1MMP2
SCHEMBL23860254 0.84 CA12 (0.41) ALDH1A1CA12CA9CA1MMP2
SCHEMBL1056101 0.84 ALDH1A1 (0.47) ALDH1A1CA12CA9CA1STAT3
SCHEMBL30918124 0.84 ALDH1A1 (0.47) ALDH1A1CA12CA9CA1STAT3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230098686-A1 NERVE SPECIFIC FLUOROPHORE FORMULATIONS FOR DIRECT AND SYSTEMIC ADMINISTRATION UNIV OREGON HEALTH & SCIENCE (US) 2023-03-30 — — US disclosed
US-20230098438-A1 OXAZINE-BASED WATER-SOLUBLE FLUOROPHORE COMPOUNDS FOR IN VIVO NERVE IMAGING OREGON HEALTH & SCIENCE UNIVERSITY (US) 2023-03-30 — — US disclosed
EP-4084829-A1 OXAZINE-BASED WATER-SOLUBLE FLUOROPHORE COMPOUNDS FOR IN VIVO NERVE IMAGING Oregon Health & Science University (US) 2022-11-09 — — EP disclosed
WO-2021158820-A1 NERVE-SPECIFIC FLUOROPHORE FORMULATIONS FOR DIRECT AND SYSTEMIC ADMINISTRATION OREGON HEALTH & SCIENCE UNIVERSITY (US) 2021-08-12 — — WO disclosed
WO-2021138116-A1 OXAZINE-BASED WATER-SOLUBLE FLUOROPHORE COMPOUNDS FOR IN VIVO NERVE IMAGING OREGON HEALTH & SCIENCE UNIVERSITY (US) 2021-07-08 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230098438-A1 OXAZINE-BASED WATER-SOLUBLE FLUOROPHORE COMPOUNDS FOR IN VIVO NERVE IMAGING GAP43, NTRK1, MAG ALDH1A1 861/4885CA12 2344/4885CA9 3156/4885
US-20230098686-A1 NERVE SPECIFIC FLUOROPHORE FORMULATIONS FOR DIRECT AND SYSTEMIC ADMINISTRATION PFAS, NPFFR2, NPFFR1 ALDH1A1 556/4885CA12 2687/4885CA9 2099/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.